Anonymous sources familiar with Musk and his companies suggest continued use of ketamine
Concerns are emerging about Elon Musk’s alleged drug use, causing unrest among executives and board members who oversee the companies he runs, according to a report. Wall Street Journal report.
Anonymous sources familiar with Musk and his companies suggest continued use of ketamine, even though Musk claimed last August that he has a prescription for the medication as an antidepressant.
The report outlines a history of Musk’s alleged use of LSD, cocaine, ecstasy and psychedelic mushrooms, primarily at private meetings.
In response to the claims, Musk’s lawyer emphasized that the billionaire undergoes regular, random drug tests at SpaceX, and consistently passes them without problems.
Musk’s public use of marijuana alongside podcaster Joe Rogan in 2018 prompted a review of his federal security clearance by the Pentagon due to his role as CEO of SpaceX.
Elon Musk addressed the allegations on
The report further suggested that Linda Johnson Rice, Tesla’s chief since 2017, decided not to seek re-election due to frustration with Musk’s behavior and alleged drug use.
Elon Musk oversees a diverse portfolio of six companies: Tesla, SpaceX, X (formerly Twitter), The Boring Co., Neuralink and xAI, an artificial intelligence startup. The revelation of Musk’s alleged drug use adds a layer of scrutiny to the businessman’s leadership of these companies.
